TSE: 4263 - SUSMED,Inc.

Yield per half year: +3.94%
Sector: Healthcare

SUSMED,Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 110.63 -100% 0 0%
P/S 28.36 75.01 -62.19%
P/BV 2.11 70.3 -97%
P/FCF -117.21 79.52 -247.39%
Ev/Ebitda -13.56 18.64 -172.75%
Ev/S 14.21 72.39 -80.36%
Ev/FCF -20.29 24.55 -182.66%
E/P -0.0127 -0.1123 -88.69%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-104.79 -77.27 35.62% -181.47 -42.26%
ROE -7.54 -9.19 -17.94%
ROA -7.12 -9.6 -25.79%
ROIC 0 9.09 -100%
ROS -104.32 -143.83 -27.47%
ROCE -7.92 6.01 -231.62%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0 -1.04 -100% 0 0%
Nеt Debt/Ebitda 13.51 12.09 11.74%
Debt/Ratio 0 0.1394 -100%
Debt/Equity 0 18.09 -100%
Debt/Net Income 0 -1.95 -100%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 2.66 -100% 0 0%
Number of years of dividend growth 0 1.27 -100%
DSI 0 0.7328 -100%
Average dividend growth 0 -49.62 -100%
Average percentage for 5 years 0 1.91 -100%
Average percentage for payments 0 33.37 -100%
Difference from average difference in sector -2.66

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
881.66 53.88 1536.34%
Growth impulse Ebitda in 5 years -98.38 12.48 -888.3%
Growth impulse Net Income in 5 years 268.83 -8.53 -3251.58%
Growth impulse FCF in 5 years 157.51 -13.75 -1245.53%
Growth impulse EPS in 5 years 243.66 -67.8 -459.38%
IP Score
3.78/10

Similar companies

Astellas Pharma Inc.

Takeda Pharmaceutical Company Limited

Terumo Corporation

Otsuka Holdings Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription